NEUROONE MEDICAL TECHNOLOGIES Corp (Form: 8-A12B, Received: 05/25/2021 08:31:58)

Date: May 25, 2021

NEUROONE MEDICAL TECHNOLOGIES CORPORATION

/s/ David Rosa

David Rosa

Chief Executive Officer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

NeuroOne Medical Technologies Corporation

(Exact name of registrant as specified in its charter)

Delaware

27-0863354

(State of incorporation or organization)

(I.R.S. Employer Identification No.)

7599 Anagram Dr., Eden Prairie, MN 55344

(Address of principal executive offices including zip code)

Securities to be registered pursuant to Section 12(b) of the Act:


Title of each class to be so registered		Name of each exchange on which each class is to be registered

Common Stock, par value $0.001 per share		The Nasdaq Stock Market LLC

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ¨

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨

Securities Act registration statement file number to which this form relates:

None

Securities to be registered pursuant to Section 12(g) of the Act:

None

Item 1. Description of Registrant’s Securities to be Registered.

A description of the securities of NeuroOne Medical Technologies Corporation, a Delaware corporation (the “Registrant”), to be registered hereunder is set forth in Exhibit 4.2 “Description of Securities” to the Registrant’s Annual Report on Form 10-K for the year ended September 30, 2020, as filed with the Securities and Exchange Commission (the “Commission”) on December 9, 2020, which Exhibit 4.2 shall be deemed to be incorporated by reference herein.

Item 2. Exhibits.

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.